Molecular Cardiac Surgery with Recirculating Delivery (MCARD): Procedure and Vector Transfer

Area of Science:

• Cardiovascular Research
• Gene Therapy
• Molecular Cardiology

Background:

• Cardiovascular diseases remain a leading global cause of death, necessitating innovative therapeutic strategies.
• Gene therapy presents a promising avenue for treating advanced cardiovascular conditions, but effective gene transfer methods are crucial.
• Current limitations in gene therapy effectiveness stem from challenges in establishing clinically relevant gene transfer techniques.

Purpose of the Study:

• To explore and evaluate novel myocardial gene transfer techniques in a large animal model.
• To assess the potential of molecular cardiac surgery with recirculating delivery for treating post-ischemic heart failure.
• To identify characteristics of an optimal gene delivery technique for cardiovascular applications.

Main Methods:

• Development and application of myocardial gene transfer using molecular cardiac surgery.
• Utilizing a large animal model of post-ischemic heart failure.
• Employing a recirculating delivery system for enhanced gene vector targeting.

Main Results:

• Demonstrated feasibility of myocardial gene transfer via molecular cardiac surgery in a large animal model.
• Evaluated the efficacy of recirculating delivery for targeting cardiac myocytes.
• Assessed key parameters for optimal gene delivery, including vector residence time and systemic exclusion.

Conclusions:

• Molecular cardiac surgery with recirculating delivery is a viable strategy for myocardial gene transfer in heart failure models.
• This technique shows potential for improving gene therapy outcomes in cardiovascular disease.
• Further research in large animal models is essential for refining gene delivery methods and understanding molecular pathways.